Clinical Trials in France / NCT07869849
Starting soon
Not applicable
A Minute for my Kidneys
NCT07869849 · tracked via the Priya Life Science France tracker
Condition(s) studied
Chronic Kidney Diseases
Investigational drug(s) / intervention(s)
Dialysis
Dialysis: Dialysis for a patient with stage V chronic kidney disease
Study summary
The purpose of this study is to evaluate the effectiveness of the "One Minute for My Kidneys" program in reducing the time it takes for participants with stage V chronic kidney disease and other comorbidities to begin dialysis.
Eligibility
Inclusion Criteria:
* Age ≥ 18 and ≤ 80;
* Participants with stage V chronic kidney disease;
* Participants with documented type 2 diabetes AND/OR documented glomerular disease (proteinuria \> 1 g/24 h) AND/OR diagnosed with heart failure as recognized by a cardiologist according to the criteria of the European Society of Cardiology;
* Participants who have and agree to use an internet connection;
* Participants who speak and understand French and are able to complete the questionnaires;
* Participants who have been informed and have signed an informed consent form;
* Participants covered by a social security program.
Exclusion Criteria:
* Inability to use the app (blindness, severe intellectual disability);
* Life expectancy of less than 6 months, as determined by the investigator;
* Significant noncompliance, as determined by the investigator;
* Participants for whom, in the event of end-stage renal disease, palliative care would be chosen over dialysis or transplantation;
* Women who are pregnant or may become pregnant (of childbearing age and not using effective contraception) or who are breastfeeding;
* Persons under legal guardianship (under legal protection or deprived of liberty by judicial or administrative decision);
* A person unable to understand the information related to the study (due to linguistic, psychological, cognitive, or other reasons);
* A participant currently enrolled in another clinical trial or study, or who has participated in another clinical trial or study that could have affected their health status within the 6 months prior to enrollment.
Primary outcome measure(s)
- Time to initiation of dialysis — Up to 24 months
Time to initiation of dialysis (scheduled and unscheduled) for participants with stage V chronic kidney disease and one or more comorbidities.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Privé La Louvière | Lille | France |
More GCS Ramsay Santé pour l'Enseignement et la Recherche trials in France
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07869849 on ClinicalTrials.gov ↗ ← All trials in France